← Leaderboards
John S Yu
Cedars-Sinai Medical Center
$7,940,413
Attributed
$7,940,413
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $715.2K · FY2005–24$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$7,940,413 · 6
By mechanism
R01$6,160,769 · 2
R21$758,699 · 2
K23$608,445 · 1
R56$412,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Julia Y Ljubimova$11,374,096
- Alexander V Ljubimov$16,915,625
- Eggehard Holler$2,913,975
- V.krishnan Ramanujan$377,850
- Chirag Gadkary Patil$212,357
Others in their field
Top investigators on “Neoplastic Cell”
- David Heimbrook · Leidos Biomedical Research, Inc.$139,710,838
- Gregory H Reaman · National Childhood Cancer Foundation$31,993,642
- Bruce W Stillman · Cold Spring Harbor Laboratory$25,455,900
- Ralph Parchment · Leidos Biomedical Research, Inc.$25,266,647
- Andrea Califano · Columbia University Health Sciences$22,374,316
- Wendell A Lim · University Of California, San Francisco$22,334,734
Research focus
Neoplastic CellGliomaBrain NeoplasmsTumorBrainAreaStem CellsGlioblastomaIn VivoCellsMediatingPropertyEndotheliumTissuesPathologicApoptosisDrug Delivery SystemsBone MarrowNerve Stem CellMigrationIn VitroEngraftmentAdultCell Motility
Grant awards (24)
Magnetofluorescent nanoplatform for glioblastoma therapy$589,225
R01 · FY2024 · CA · contact PI
Magnetofluorescent nanoplatform for glioblastoma therapy$607,833
R01 · FY2023 · CA · contact PI
Magnetofluorescent nanoplatform for glioblastoma therapy$608,922
R01 · FY2022 · CA · contact PI
Magnetofluorescent nanoplatform for glioblastoma therapy$638,098
R01 · FY2021 · CA · contact PI
Magnetofluorescent nanoplatform for glioblastoma therapy$623,483
R01 · FY2020 · CA · contact PI
Bone marrow derived neural stem cell therapy for glioma$361,660
R01 · FY2014 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$352,527
R01 · FY2013 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$365,313
R01 · FY2012 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$365,313
R01 · FY2011 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$412,500
R56 · FY2010 · NS · contact PI
Targeting cancer stem cells for brain tumor therapy$219,375
R21 · FY2009 · CA · contact PI
Targeting cancer stem cells for brain tumor therapy$182,813
R21 · FY2008 · CA · contact PI
Bone marrow derived neural stem cell therapy for glioma$307,850
R01 · FY2007 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$481,079
R01 · FY2006 · NS · contact PI
Human Bone Marrow Derived Neural Stem Cell Therapy$176,136
R21 · FY2006 · NS · contact PI
Bone marrow derived neural stem cell therapy for glioma$491,339
R01 · FY2005 · NS
Human Bone Marrow Derived Neural Stem Cell Therapy$180,375
R21 · FY2005 · NS
Bone marrow derived neural stem cell therapy for glioma$43,452
R01 · FY2005 · NS
Bone marrow derived neural stem cell therapy for glioma$324,675
R01 · FY2004 · NS
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA$121,689
K23 · FY2004 · NS
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA$121,689
K23 · FY2003 · NS
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA$121,689
K23 · FY2002 · NS
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA$121,689
K23 · FY2001 · NS
ACTIVE IMMUNOTHERAPY FOR GLIOBLASTOMA$121,689
K23 · FY2000 · NS